After the registration of NeuroSolve Clinical Trial on PACTR (Pan African Clinical Trial Registry), we are now glad to announce that NeuroSolve’s Clinical Trial has been successfully registered also on ClinicalTrial.gov.
NeuroSolve is a four-year project funded by EDCTP3, and started on May 1, 2023. The African-European research consortium involves the University of Dar es Salaam (UDSM – Tanzania), Sokoine University of Agriculture (SUA – Tanzania), University of Zambia (UNZA – Zambia), Revolution Worldwide Srl – Impresa Sociale (R-EvoWW – Italy) and Universiteit Ghent (UGent – Belgium). NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.
